Shurong Chang, MD
Dermatology · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 9 carriers
- Offices
- 2
Offices
2 locations · East Bay Dermatology Medical Group Inc. · 8 clinicians in this group
Looking this up.
Hospitals listed: Washington Hospital. That is not proof they admit you there this week.
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A122412 · Current
Licensed to practise in California · since 2012 · expires 2027-11-30 · University of Texas Southwestern Medical School at Dallas.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$529,811
Medicare paid this office $529,811 for 1,559 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 922 | $109,871 | $76 |
| Return visit (30+ min) | 420 | $83,628 | $108 |
| Destruction of skin growth, 1-14 growths | 303 | $52,305 | $111 |
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 24 | $43,259 | $130 |
| Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 22 | $38,945 | $160 |
See all 28 services
| Short return visit (20+ min) | 922 | $109,871 | $76 |
| Return visit (30+ min) | 420 | $83,628 | $108 |
| Destruction of skin growth, 1-14 growths | 303 | $52,305 | $111 |
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 24 | $43,259 | $130 |
| Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 22 | $38,945 | $160 |
| Destruction of precancer skin growth, 1 growth | 375 | $28,444 | $51 |
| New patient visit (30+ min) | 274 | $23,474 | $86 |
| Biopsy of related skin growth, first growth | 142 | $15,158 | $91 |
| Treatment of inflammatory skin disease using laser, 250.0-500.0 sq cm | 13 | $14,490 | $172 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 38 | $12,475 | $304 |
| Destruction of precancer skin growth, 2-14 growths | 287 | $12,083 | $7 |
| Destruction of precancer skin growth, 15 or more growths | 48 | $11,588 | $159 |
| New patient visit (45+ min) | 92 | $11,429 | $124 |
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 22 | $6,592 | None |
| Short return visit | 117 | $6,367 | $49 |
| Injection into skin growth, 1-7 growths | 66 | $4,839 | $48 |
| Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | 13 | $4,617 | $308 |
| Punch biopsy, first skin growth | 37 | $4,579 | $121 |
| Application of light by qualified health care professional to destroy precancer skin growth | 16 | $4,168 | $245 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 27 | $3,562 | $123 |
| New patient visit (15+ min) | 39 | $2,068 | $53 |
| Injection into skin growth, more than 7 growths | 15 | $1,801 | $62 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 11 | $1,247 | $113 |
| Biopsy of related skin growth, each additional growth | 21 | $1,183 | $51 |
| Biopsy of ear | 11 | $1,029 | $86 |
| Injection of drug or substance under skin or into muscle | 28 | $973 | $13 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 89 | $194 | None |
| Tissue fungi or parasites | 11 | $54 | $4 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 40 | More than 84% of doctors who do this |
| Removal of skin lesions | 1357 | More than 96% of doctors who do this |
| Removal or shaving of skin growth | 33 | More than 76% of doctors who do this |
| Skin biopsy | 183 | More than 84% of doctors who do this |
Who their Medicare patients are
1,559 Original Medicare patients in 2024. Average age 75 · Under 65 7% · 85 and older 17% · Women 55% · Also on Medicaid 39% · Health risk score 1.16. Above the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 75% · Diabetes 39% · Coronary heart disease 27% · Chronic kidney disease 26% · Heart failure 15% · Atrial fibrillation 15% · Cancer 12% · COPD 12% · Depression 12% · Stroke 8% · Dementia 6%.
The office billed $1,637,573, Medicare allowed $730,593 and paid $529,811; for 12,494 services of 74 kinds; $7,103 of it was for drugs given in the office and $522,708 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,559 | 12,494 | 75 | 1.16 | $1,637,573 | $529,811 |
| 2023 | 1,486 | 10,038 | 75 | 1.11 | $956,207 | $461,932 |
| 2022 | 1,406 | 8,925 | 75 | 1.09 | $1,087,328 | $493,664 |
| 2021 | 1,300 | 8,479 | 75 | 1.17 | $824,025 | $486,404 |
| 2020 | 918 | 7,305 | 75 | 1.24 | $479,231 | $305,665 |
| 2019 | 1,204 | 6,783 | 75 | 1.33 | $533,361 | $343,182 |
| 2018 | 1,037 | 6,400 | 74 | 1.36 | $397,997 | $269,847 |
| 2017 | 734 | 2,816 | 73 | 1.56 | $214,022 | $149,924 |
| 2016 | 347 | 1,369 | 76 | 1.44 | $84,602 | $61,815 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 23 services
| Short return visit (20+ min) | 892 | $107,046 | $76 |
| Return visit (30+ min) | 353 | $67,636 | $111 |
| Destruction of skin growth, 1-14 growths | 265 | $45,339 | $113 |
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 22 | $35,479 | $130 |
| Destruction of precancer skin growth, 1 growth | 329 | $24,397 | $52 |
| New patient visit (30+ min) | 228 | $20,365 | $89 |
| Biopsy of related skin growth, first growth | 144 | $14,746 | $93 |
| Destruction of precancer skin growth, 2-14 growths | 264 | $13,530 | $7 |
| Destruction of precancer skin growth, 15 or more growths | 53 | $12,413 | $168 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 36 | $12,369 | $309 |
| New patient visit (45+ min) | 77 | $11,172 | $145 |
| Short return visit | 120 | $6,559 | $50 |
| Punch biopsy, first skin growth | 39 | $5,236 | $125 |
| Injection into skin growth, 1-7 growths | 62 | $4,539 | $47 |
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 16 | $4,131 | None |
| New patient visit (15+ min) | 62 | $3,206 | $52 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 16 | $2,033 | $120 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 11 | $1,601 | $146 |
| Injection into skin growth, more than 7 growths | 13 | $1,535 | $70 |
| Biopsy of related skin growth, each additional growth | 18 | $1,050 | $53 |
| Biopsy of ear | 11 | $1,039 | $94 |
| Injection of drug or substance under skin or into muscle | 15 | $594 | $14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 76 | $145 | None |
2022: 27 services
| Short return visit (20+ min) | 933 | $119,902 | $78 |
| Return visit (30+ min) | 246 | $41,898 | $113 |
| Destruction of skin growth, 1-14 growths | 241 | $38,495 | $111 |
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 24 | $36,506 | $127 |
| Treatment of inflammatory skin disease using laser, more than 500.0 sq cm | 11 | $27,774 | $239 |
| Treatment of inflammatory skin disease using laser, 250.0-500.0 sq cm | 14 | $27,323 | $176 |
| Destruction of precancer skin growth, 1 growth | 330 | $25,545 | $53 |
| Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 13 | $23,785 | $163 |
| New patient visit (30+ min) | 265 | $23,178 | $87 |
| Biopsy of related skin growth, first growth | 169 | $19,303 | $98 |
| Destruction of precancer skin growth, 15 or more growths | 62 | $16,514 | $165 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 38 | $14,557 | $310 |
| Destruction of precancer skin growth, 2-14 growths | 265 | $13,004 | $7 |
| Short return visit | 136 | $7,847 | $49 |
| Punch biopsy, first skin growth | 51 | $6,458 | $127 |
| New patient visit (45+ min) | 39 | $4,945 | $127 |
| Injection into skin growth, 1-7 growths | 61 | $3,820 | $48 |
| Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | 11 | $3,507 | $319 |
| New patient visit (15+ min) | 56 | $3,500 | $62 |
| Pathology examination of tissue using a microscope, intermediate complexity | 27 | $3,023 | $72 |
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 11 | $2,525 | None |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 19 | $2,344 | $117 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 12 | $2,125 | $125 |
| Simple or single drainage of skin abscess | 15 | $2,097 | $123 |
| Biopsy of related skin growth, each additional growth | 20 | $1,165 | $53 |
| Injection of drug or substance under skin or into muscle | 17 | $494 | $14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 79 | $220 | None |
2021: 23 services
| Short return visit (20+ min) | 899 | $107,105 | $74 |
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 34 | $51,638 | $126 |
| Return visit (30+ min) | 262 | $38,017 | $108 |
| Destruction of skin growth, 1-14 growths | 200 | $33,715 | $115 |
| New patient visit (30+ min) | 302 | $27,865 | $92 |
| Destruction of precancer skin growth, 1 growth | 314 | $24,183 | $55 |
| Biopsy of related skin growth, first growth | 197 | $23,068 | $101 |
| Destruction of precancer skin growth, 15 or more growths | 72 | $19,245 | $164 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 35 | $12,986 | $317 |
| Destruction of precancer skin growth, 2-14 growths | 265 | $11,426 | $6 |
| Pathology examination of tissue using a microscope, intermediate complexity | 85 | $9,603 | $70 |
| Short return visit | 108 | $5,489 | $46 |
| Punch biopsy, first skin growth | 33 | $4,540 | $130 |
| Injection into skin growth, 1-7 growths | 53 | $4,041 | $48 |
| New patient visit (45+ min) | 26 | $3,678 | $141 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 11 | $3,526 | $321 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 17 | $2,371 | $119 |
| Injection into skin growth, more than 7 growths | 15 | $2,329 | $65 |
| Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | 11 | $2,269 | $206 |
| Biopsy of related skin growth, each additional growth | 30 | $1,765 | $55 |
| New patient visit (15+ min) | 12 | $783 | $65 |
| Pathology examination of tissue using a microscope, moderately low complexity | 14 | $613 | $44 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 69 | $162 | None |
2020: 21 services
| Short return visit (20+ min) | 547 | $52,788 | $64 |
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 32 | $38,603 | $125 |
| Destruction of skin growth, 1-14 growths | 135 | $18,785 | $103 |
| Destruction of precancer skin growth, 1 growth | 204 | $15,028 | $55 |
| Return visit (30+ min) | 92 | $11,985 | $102 |
| Short return visit | 226 | $11,316 | $39 |
| Biopsy of related skin growth, first growth | 92 | $10,173 | $99 |
| Pathology examination of tissue using a microscope, intermediate complexity | 97 | $10,031 | $71 |
| Destruction of precancer skin growth, 15 or more growths | 42 | $8,577 | $156 |
| New patient visit (15+ min) | 125 | $7,708 | $62 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 23 | $7,554 | $302 |
| Destruction of precancer skin growth, 2-14 growths | 175 | $6,761 | $6 |
| New patient visit (30+ min) | 72 | $6,476 | $90 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 13 | $4,147 | $296 |
| Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | 14 | $4,055 | $290 |
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 13 | $2,986 | None |
| Injection into skin growth, 1-7 growths | 38 | $2,393 | $42 |
| Punch biopsy, first skin growth | 16 | $2,094 | $131 |
| Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | 12 | $1,772 | $136 |
| Biopsy of related skin growth, each additional growth | 12 | $714 | $55 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 47 | $113 | None |
2019: 21 services
| Short return visit (20+ min) | 620 | $66,075 | $65 |
| Destruction of skin growth, 1-14 growths | 205 | $32,796 | $106 |
| Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 13 | $30,257 | $159 |
| Short return visit | 445 | $22,888 | $39 |
| Destruction of precancer skin growth, 1 growth | 227 | $17,850 | $58 |
| New patient visit (15+ min) | 248 | $16,043 | $65 |
| Biopsy of related skin growth, first growth | 132 | $13,933 | $95 |
| Pathology examination of tissue using a microscope, intermediate complexity | 134 | $12,697 | $67 |
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 22 | $12,154 | $80 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 34 | $10,695 | $297 |
| New patient visit (30+ min) | 94 | $8,169 | $87 |
| Destruction of precancer skin growth, 2-14 growths | 197 | $7,443 | $5 |
| Destruction of precancer skin growth, 15 or more growths | 33 | $6,279 | $146 |
| Return visit (30+ min) | 56 | $5,924 | $96 |
| Punch biopsy, first skin growth | 42 | $5,319 | $124 |
| Injection into skin growth, 1-7 growths | 50 | $4,259 | $47 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 13 | $3,852 | $257 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 16 | $2,315 | $129 |
| Pathology examination of tissue using a microscope, moderately low complexity | 20 | $872 | $42 |
| Biopsy of related skin growth, each additional growth | 16 | $865 | $54 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 64 | $221 | None |
2018: 20 services
| Short return visit (20+ min) | 468 | $41,631 | $59 |
| Short return visit | 454 | $23,405 | $38 |
| Destruction of skin growth, 1-14 growths | 162 | $23,169 | $104 |
| Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 13 | $21,027 | $145 |
| Biopsy of single growth of skin and/or tissue | 156 | $16,428 | $93 |
| Destruction of precancer skin growth, 1 growth | 203 | $15,516 | $54 |
| New patient visit (15+ min) | 232 | $13,771 | $59 |
| Pathology examination of tissue using a microscope, intermediate complexity | 112 | $10,180 | $63 |
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 16 | $9,328 | $72 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 19 | $5,756 | $288 |
| Destruction of precancer skin growth, 2-14 growths | 172 | $5,665 | $5 |
| Injection into skin growth, 1-7 growths | 58 | $4,111 | $47 |
| New patient visit (30+ min) | 50 | $3,899 | $78 |
| Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | 16 | $3,516 | $220 |
| Application of ultraviolet light to skin | 23 | $3,370 | $18 |
| Destruction of precancer skin growth, 15 or more growths | 22 | $2,963 | $129 |
| Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 15 | $2,049 | $137 |
| Pathology examination of tissue using a microscope, moderately low complexity | 20 | $845 | $40 |
| Biopsy of each additional growth of skin and/or tissue | 14 | $472 | $29 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 68 | $196 | None |
2017: 16 services
| Short return visit (20+ min) | 326 | $31,130 | $62 |
| Short return visit | 280 | $13,281 | $38 |
| Destruction of skin growth, 1-14 growths | 85 | $13,134 | $102 |
| Biopsy of single growth of skin and/or tissue | 115 | $11,675 | $93 |
| New patient visit (15+ min) | 174 | $10,682 | $61 |
| Destruction of precancer skin growth, 1 growth | 118 | $8,096 | $54 |
| New patient visit (30+ min) | 66 | $5,696 | $86 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 16 | $5,258 | $292 |
| Pathology examination of tissue using a microscope, intermediate complexity | 57 | $4,755 | $65 |
| Destruction of precancer skin growth, 2-14 growths | 102 | $3,281 | $5 |
| Injection into skin growth, 1-7 growths | 38 | $2,863 | $49 |
| Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | 11 | $2,570 | $234 |
| Application of ultraviolet light to skin | 11 | $1,787 | $21 |
| Destruction of precancer skin growth, 15 or more growths | 12 | $1,703 | $131 |
| Injection of drug or substance under skin or into muscle | 12 | $546 | $23 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 51 | $189 | None |
2016: 11 services
| Short return visit (20+ min) | 197 | $17,135 | $66 |
| Destruction of precancer skin growth, 1 growth | 103 | $6,989 | $57 |
| Destruction of skin growth, 1-14 growths | 41 | $6,242 | $106 |
| Biopsy of single growth of skin and/or tissue | 54 | $5,277 | $96 |
| New patient visit (15+ min) | 79 | $5,231 | $66 |
| Short return visit | 68 | $3,383 | $39 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 11 | $3,120 | $284 |
| Destruction of precancer skin growth, 2-14 growths | 90 | $2,953 | $5 |
| New patient visit (30+ min) | 20 | $1,873 | $94 |
| Return visit (30+ min) | 11 | $1,080 | $98 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $32 | None |
Medicaid work
$460,674 in 2024
Medicaid paid $460,674 for 5,209 billed services this clinician did in 2024, up to 209 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 1,403 | $155,438 |
| Short return visit (20+ min) | 1,656 | $125,084 |
| New patient visit (30+ min) | 560 | $58,174 |
| New patient visit (45+ min) | 229 | $33,271 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 303 | $31,239 |
| Excimer laser treatment for psoriasis; total area less than 250 sq cm | 154 | $21,003 |
| Injection, intralesional; up to and including 7 lesions | 224 | $13,135 |
| Photochemotherapy; tar and ultraviolet B (Goeckerman treatment) or petrolatum and ultraviolet B | 160 | $12,662 |
| Short return visit | 96 | $5,209 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 361 | $1,973 |
| Injection, intralesional; more than 7 lesions | 27 | $1,377 |
| Punch biopsy of skin (including simple closure, when performed); single lesion | 12 | $1,066 |
| 2024 | 5,209 | 13 | 209 | $460,674 |
| 2023 | 5,640 | 14 | 195 | $380,311 |
| 2022 | 5,530 | 16 | 186 | $426,477 |
| 2021 | 4,304 | 10 | 120 | $433,004 |
| 2020 | 2,861 | 9 | 100 | $245,114 |
| 2019 | 3,599 | 9 | 94 | $348,733 |
| 2018 | 3,369 | 11 | 91 | $296,208 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 1,767 | $114,279 |
| Return visit (30+ min) | 1,423 | $114,060 |
| New patient visit (30+ min) | 552 | $47,069 |
| New patient visit (45+ min) | 240 | $28,180 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 344 | $27,587 |
| Photochemotherapy; tar and ultraviolet B (Goeckerman treatment) or petrolatum and ultraviolet B | 280 | $19,055 |
| Injection, intralesional; up to and including 7 lesions | 332 | $13,869 |
| Excimer laser treatment for psoriasis; total area less than 250 sq cm | 37 | $5,581 |
| Short return visit | 92 | $3,861 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 49 | $2,026 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 50 | $1,817 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 449 | $1,753 |
2022
| Short return visit (20+ min) | 1,994 | $134,731 |
| Excimer laser treatment for psoriasis; total area less than 250 sq cm | 392 | $88,013 |
| Return visit (30+ min) | 905 | $71,390 |
| New patient visit (30+ min) | 641 | $43,981 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 298 | $28,870 |
| Photochemotherapy; tar and ultraviolet B (Goeckerman treatment) or petrolatum and ultraviolet B | 198 | $20,062 |
| Injection, intralesional; up to and including 7 lesions | 279 | $11,858 |
| New patient visit (45+ min) | 121 | $10,951 |
| Short return visit | 136 | $5,842 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 43 | $3,741 |
| Punch biopsy of skin (including simple closure, when performed); single lesion | 29 | $2,523 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 425 | $2,094 |
2021
| Short return visit (20+ min) | 1,719 | $137,318 |
| Return visit (30+ min) | 783 | $86,318 |
| Excimer laser treatment for psoriasis; total area less than 250 sq cm | 259 | $59,579 |
| New patient visit (30+ min) | 558 | $58,937 |
| Photochemotherapy; tar and ultraviolet B (Goeckerman treatment) or petrolatum and ultraviolet B | 385 | $54,724 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 156 | $24,674 |
| Injection, intralesional; up to and including 7 lesions | 103 | $7,989 |
| Short return visit | 29 | $2,293 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 297 | $1,171 |
| ACNE SURGERY | 15 | $0 |
2020
| Short return visit (20+ min) | 1,255 | $91,655 |
| New patient visit (30+ min) | 370 | $46,482 |
| Photochemotherapy; tar and ultraviolet B (Goeckerman treatment) or petrolatum and ultraviolet B | 208 | $29,632 |
| Short return visit | 448 | $20,160 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 119 | $19,495 |
| Excimer laser treatment for psoriasis; total area less than 250 sq cm | 75 | $18,909 |
| Return visit (30+ min) | 81 | $11,425 |
| Injection, intralesional; up to and including 7 lesions | 84 | $6,424 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 221 | $933 |
2019
| Excimer laser treatment for psoriasis; total area less than 250 sq cm | 593 | $147,991 |
| Short return visit (20+ min) | 1,193 | $82,899 |
| New patient visit (30+ min) | 329 | $40,544 |
| Short return visit | 879 | $37,176 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 158 | $23,198 |
| Injection, intralesional; up to and including 7 lesions | 127 | $9,630 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 74 | $6,183 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 216 | $1,114 |
| ACNE SURGERY | 30 | $0 |
2018
| Short return visit (20+ min) | 958 | $71,436 |
| Excimer laser treatment for psoriasis; total area less than 250 sq cm | 262 | $64,849 |
| Short return visit | 1,046 | $46,016 |
| New patient visit (30+ min) | 299 | $44,948 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 225 | $33,032 |
| Injection, intralesional; up to and including 7 lesions | 199 | $15,772 |
| Photochemotherapy; tar and ultraviolet B (Goeckerman treatment) or petrolatum and ultraviolet B | 83 | $9,334 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 81 | $7,795 |
| Service | 12 | $1,707 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 192 | $1,318 |
| ACNE SURGERY | 12 | $0 |
Drugs they prescribed that Part D paid
$1,363,076
Pharmacies billed $1,363,076 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,440) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
3,214 generic and 226 brand-name prescriptions · $1,363,076 in drug cost · 105 antibiotic prescriptions to 52 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Skyrizi | 21 | $445,887 | $21,233 |
| Dupixent | 54 | $198,014 | $3,667 |
| Taltz | 19 | $126,281 | $6,646 |
| Adbry | 19 | $72,698 | $3,826 |
| Betamethasone Dipropionate | 515 | $27,281 | $53 |
See all 35 drugs
| Skyrizi | 21 | $445,887 | $21,233 |
| Dupixent | 54 | $198,014 | $3,667 |
| Taltz | 19 | $126,281 | $6,646 |
| Adbry | 19 | $72,698 | $3,826 |
| Betamethasone Dipropionate | 515 | $27,281 | $53 |
| Opzelura | 12 | $23,940 | $1,995 |
| Clobetasol Propionate | 271 | $22,776 | $84 |
| Fluocinonide | 271 | $12,000 | $44 |
| Ketoconazole | 378 | $7,497 | $20 |
| Metronidazole | 59 | $4,729 | $80 |
| Betamethasone Diprop Augmented | 86 | $3,265 | $38 |
| Clindamycin Phosphate | 78 | $2,753 | $35 |
| Triamcinolone Acetonide | 400 | $2,715 | $7 |
| Tretinoin | 33 | $2,564 | $78 |
| Selenium Sulfide | 234 | $2,547 | $11 |
| Calcipotriene | 15 | $2,509 | $167 |
| Doxycycline Monohydrate | 75 | $1,988 | $27 |
| Halobetasol Propionate | 31 | $1,970 | $64 |
| Ciclopirox | 50 | $1,311 | $26 |
| Econazole Nitrate | 37 | $1,235 | $33 |
| Fluorouracil | 19 | $1,208 | $64 |
| Desonide | 36 | $1,183 | $33 |
| Hydrocortisone | 189 | $1,127 | $6 |
| Fluticasone Propionate | 40 | $610 | $15 |
| Nystatin | 18 | $555 | $31 |
| Clotrimazole | 27 | $545 | $20 |
| Fluocinolone Acetonide | 13 | $543 | $42 |
| Hydroxyzine | 48 | $506 | $11 |
| Hydroxychloroquine Sulfate | 23 | $504 | $22 |
| Ciclopirox | 17 | $502 | $30 |
| Prednisone | 48 | $376 | $8 |
| Mupirocin | 54 | $336 | $6 |
| Minoxidil | 13 | $263 | $20 |
| Dutasteride | 16 | $191 | $12 |
| Terbinafine | 12 | $62 | $5 |
Year by year
| 2024 | 3,440 | 798 | 0% (0) | 7% | $1,363,076 |
| 2023 | 3,072 | 758 | 0% (0) | None | $1,070,781 |
| 2022 | 2,672 | 712 | 0% (0) | 8% | $646,305 |
| 2021 | 2,496 | 717 | 0% (0) | 9% | $493,314 |
| 2020 | 2,397 | 690 | 0% (0) | 13% | $343,297 |
| 2019 | 2,649 | 805 | 0% (0) | None | $360,365 |
| 2018 | 2,445 | 770 | None | None | $233,100 |
| 2017 | 1,633 | 548 | 0% (0) | None | $121,347 |
| 2016 | 1,448 | 433 | None | 10% | $146,469 |
| 2015 | 639 | 257 | None | 8% | $109,125 |
| 2014 | 250 | 112 | None | None | $31,350 |
| 2013 | 198 | 92 | 0% (0) | None | $15,421 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 35 drugs
| Skyrizi | 12 | $240,468 | $20,039 |
| Taltz | 18 | $140,389 | $7,799 |
| Humira(Cf) | 12 | $89,720 | $7,477 |
| Otezla | 17 | $78,492 | $4,617 |
| Dupixent | 16 | $61,888 | $3,868 |
| Dupixent | 16 | $61,790 | $3,862 |
| Opzelura | 12 | $43,376 | $3,615 |
| Betamethasone Dipropionate | 470 | $37,538 | $80 |
| Fluocinonide | 300 | $23,875 | $80 |
| Clobetasol Propionate | 147 | $20,575 | $140 |
| Ketoconazole | 357 | $8,776 | $25 |
| Calcipotriene | 19 | $7,174 | $378 |
| Betamethasone Diprop Augmented | 128 | $6,636 | $52 |
| Triamcinolone Acetonide | 425 | $4,202 | $10 |
| Metronidazole | 48 | $3,952 | $82 |
| Clindamycin Phosphate | 71 | $3,557 | $50 |
| Tretinoin | 22 | $3,181 | $145 |
| Selenium Sulfide | 201 | $2,519 | $13 |
| Dapsone | 11 | $2,337 | $212 |
| Econazole Nitrate | 37 | $2,049 | $55 |
| Doxycycline Monohydrate | 67 | $1,905 | $28 |
| Nystatin-Triamcinolone | 14 | $1,639 | $117 |
| Tacrolimus | 11 | $1,549 | $141 |
| Hydrocortisone | 192 | $1,461 | $8 |
| Fluocinolone Acetonide | 13 | $1,278 | $98 |
| Ciclopirox | 34 | $1,265 | $37 |
| Desonide | 18 | $1,038 | $58 |
| Fluticasone Propionate | 47 | $869 | $18 |
| Clotrimazole | 37 | $863 | $23 |
| Hydroxyzine | 34 | $645 | $19 |
| Dutasteride | 13 | $562 | $43 |
| Ciclopirox | 14 | $510 | $36 |
| Mupirocin | 39 | $477 | $12 |
| Prednisone | 22 | $289 | $13 |
| Finasteride | 13 | $130 | $10 |
2022: 31 drugs
| Humira(Cf) | 18 | $124,615 | $6,923 |
| Enbrel | 12 | $83,163 | $6,930 |
| Dupixent | 22 | $77,256 | $3,512 |
| Dupixent | 11 | $37,172 | $3,379 |
| Fluocinonide | 342 | $25,274 | $74 |
| Betamethasone Dipropionate | 244 | $20,774 | $85 |
| Betamethasone Diprop Augmented | 197 | $18,544 | $94 |
| Clobetasol Propionate | 121 | $12,815 | $106 |
| Ketoconazole | 381 | $8,968 | $24 |
| Tacrolimus | 18 | $5,603 | $311 |
| Dapsone | 13 | $4,430 | $341 |
| Triamcinolone Acetonide | 374 | $4,267 | $11 |
| Clindamycin Phosphate | 59 | $3,738 | $63 |
| Metronidazole | 33 | $3,098 | $94 |
| Econazole Nitrate | 27 | $3,082 | $114 |
| Tretinoin | 30 | $2,450 | $82 |
| Halobetasol Propionate | 21 | $2,147 | $102 |
| Doxycycline Monohydrate | 73 | $1,991 | $27 |
| Fluorouracil | 13 | $1,667 | $128 |
| Desonide | 19 | $1,279 | $67 |
| Ciclopirox | 22 | $1,225 | $56 |
| Fluticasone Propionate | 49 | $1,160 | $24 |
| Hydrocortisone | 150 | $1,120 | $7 |
| Clotrimazole | 39 | $1,098 | $28 |
| Nystatin | 22 | $956 | $43 |
| Selenium Sulfide | 64 | $773 | $12 |
| Mupirocin | 45 | $536 | $12 |
| Minocycline | 14 | $510 | $36 |
| Ciclopirox | 11 | $403 | $37 |
| Hydroxyzine | 31 | $301 | $10 |
| Prednisone | 18 | $253 | $14 |
2021: 32 drugs
| Taltz | 12 | $75,715 | $6,310 |
| Dupixent | 11 | $36,901 | $3,355 |
| Betamethasone Diprop Augmented | 302 | $27,650 | $92 |
| Fluocinonide | 281 | $23,183 | $83 |
| Betamethasone Dipropionate | 158 | $17,352 | $110 |
| Ketoconazole | 302 | $9,508 | $31 |
| Clobetasol Propionate | 66 | $9,270 | $140 |
| Tacrolimus | 20 | $8,408 | $420 |
| Pimecrolimus | 13 | $5,274 | $406 |
| Triamcinolone Acetonide | 435 | $4,895 | $11 |
| Metronidazole | 41 | $4,062 | $99 |
| Dapsone | 14 | $3,794 | $271 |
| Clindamycin Phosphate | 56 | $3,514 | $63 |
| Doxycycline Monohydrate | 70 | $1,979 | $28 |
| Fluorouracil | 19 | $1,916 | $101 |
| Tretinoin | 26 | $1,815 | $70 |
| Selenium Sulfide | 141 | $1,669 | $12 |
| Fluocinolone Acetonide | 11 | $958 | $87 |
| Fluconazole | 13 | $956 | $74 |
| Hydrocortisone | 110 | $791 | $7 |
| Ciclopirox | 16 | $745 | $47 |
| Clotrimazole | 36 | $694 | $19 |
| Desonide | 17 | $677 | $40 |
| Ciclopirox | 13 | $581 | $45 |
| Fluticasone Propionate | 24 | $576 | $24 |
| Nystatin | 16 | $551 | $34 |
| Minocycline | 12 | $513 | $43 |
| Mupirocin | 38 | $324 | $9 |
| Acyclovir | 18 | $190 | $11 |
| Hydroxyzine | 12 | $127 | $11 |
| Cephalexin | 11 | $100 | $9 |
| Prednisone | 13 | $87 | $7 |
2020: 29 drugs
| Dupixent | 14 | $45,718 | $3,266 |
| Betamethasone Diprop Augmented | 294 | $25,322 | $86 |
| Fluocinonide | 231 | $17,255 | $75 |
| Betamethasone Dipropionate | 136 | $12,146 | $89 |
| Pimecrolimus | 14 | $9,450 | $675 |
| Ketoconazole | 236 | $8,033 | $34 |
| Clobetasol Propionate | 65 | $6,723 | $103 |
| Fluorouracil | 20 | $5,172 | $259 |
| Triamcinolone Acetonide | 424 | $4,689 | $11 |
| Metronidazole | 36 | $3,959 | $110 |
| Clindamycin Phosphate | 62 | $3,818 | $62 |
| Dapsone | 12 | $3,586 | $299 |
| Calcipotriene | 13 | $3,177 | $244 |
| Doxycycline Monohydrate | 84 | $3,056 | $36 |
| Fluocinolone Acetonide | 34 | $2,972 | $87 |
| Tretinoin | 32 | $2,592 | $81 |
| Selenium Sulfide | 150 | $1,900 | $13 |
| Minocycline | 26 | $1,191 | $46 |
| Hydrocortisone | 141 | $1,038 | $7 |
| Fluticasone Propionate | 30 | $826 | $28 |
| Ciclopirox | 15 | $590 | $39 |
| Clotrimazole | 31 | $500 | $16 |
| Mupirocin | 51 | $476 | $9 |
| Ciclopirox | 15 | $451 | $30 |
| Hydroxyzine | 31 | $411 | $13 |
| Nystop | 12 | $288 | $24 |
| Acyclovir | 20 | $279 | $14 |
| Valacyclovir | 11 | $140 | $13 |
| Cephalexin | 13 | $61 | $5 |
2019: 28 drugs
| Dupixent | 22 | $64,575 | $2,935 |
| Betamethasone Diprop Augmented | 332 | $25,446 | $77 |
| Fluocinonide | 259 | $19,471 | $75 |
| Betamethasone Dipropionate | 151 | $13,086 | $87 |
| Ketoconazole | 257 | $7,621 | $30 |
| Imiquimod | 12 | $6,928 | $577 |
| Triamcinolone Acetonide | 513 | $6,574 | $13 |
| Metronidazole | 61 | $6,475 | $106 |
| Clobetasol Propionate | 43 | $6,422 | $149 |
| Clindamycin Phosphate | 82 | $6,101 | $74 |
| Fluorouracil | 36 | $5,714 | $159 |
| Doxycycline Monohydrate | 120 | $4,283 | $36 |
| Tretinoin | 21 | $1,823 | $87 |
| Selenium Sulfide | 122 | $1,518 | $12 |
| Fluocinolone Acetonide | 13 | $1,338 | $103 |
| Hydrocortisone | 171 | $1,148 | $7 |
| Fluticasone Propionate | 46 | $1,047 | $23 |
| Doxycycline Hyclate | 17 | $987 | $58 |
| Ciclopirox | 20 | $885 | $44 |
| Permethrin | 14 | $869 | $62 |
| Ciclopirox | 18 | $821 | $46 |
| Clotrimazole | 36 | $801 | $22 |
| Minocycline | 25 | $661 | $26 |
| Mupirocin | 57 | $621 | $11 |
| Hydroxyzine | 36 | $493 | $14 |
| Valacyclovir | 13 | $341 | $26 |
| Nystatin | 14 | $175 | $12 |
| Cephalexin | 12 | $87 | $7 |
2018: 26 drugs
| Otezla | 13 | $43,387 | $3,337 |
| Betamethasone Diprop Augmented | 308 | $31,435 | $102 |
| Fluocinonide | 282 | $27,606 | $98 |
| Clobetasol Propionate | 63 | $13,663 | $217 |
| Betamethasone Dipropionate | 102 | $9,157 | $90 |
| Clindamycin Phosphate | 86 | $8,461 | $98 |
| Ketoconazole | 224 | $8,390 | $37 |
| Triamcinolone Acetonide | 412 | $5,552 | $13 |
| Metronidazole | 57 | $5,360 | $94 |
| Finacea | 14 | $4,739 | $338 |
| Fluorouracil | 34 | $4,346 | $128 |
| Calcipotriene | 17 | $3,837 | $226 |
| Doxycycline Monohydrate | 115 | $3,010 | $26 |
| Selenium Sulfide | 91 | $1,922 | $21 |
| Fluocinolone Acetonide | 16 | $1,740 | $109 |
| Fluticasone Propionate | 74 | $1,465 | $20 |
| Hydrocortisone | 134 | $934 | $7 |
| Clotrimazole | 39 | $904 | $23 |
| Hydroxyzine | 34 | $809 | $24 |
| Minocycline | 21 | $779 | $37 |
| Ciclopirox | 20 | $694 | $35 |
| Doxycycline Hyclate | 21 | $686 | $33 |
| Mupirocin | 53 | $525 | $10 |
| Ciclopirox | 11 | $510 | $46 |
| Nystatin | 12 | $299 | $25 |
| Prednisone | 12 | $63 | $5 |
2017: 18 drugs
| Clobetasol Propionate | 113 | $23,207 | $205 |
| Fluocinonide | 197 | $21,123 | $107 |
| Betamethasone Dipropionate | 157 | $15,946 | $102 |
| Betamethasone Dipropionate | 86 | $8,943 | $104 |
| Clindamycin Phosphate | 79 | $6,414 | $81 |
| Metronidazole | 44 | $5,592 | $127 |
| Ketoconazole | 165 | $5,524 | $33 |
| Triamcinolone Acetonide | 259 | $3,606 | $14 |
| Clotrimazole | 57 | $1,724 | $30 |
| Fluticasone Propionate | 65 | $1,439 | $22 |
| Doxycycline Monohydrate | 68 | $1,119 | $16 |
| Ciclopirox | 21 | $703 | $33 |
| Acyclovir | 14 | $683 | $49 |
| Selenium Sulfide | 32 | $629 | $20 |
| Hydroxyzine | 20 | $619 | $31 |
| Hydrocortisone | 62 | $521 | $8 |
| Doxycycline Hyclate | 12 | $469 | $39 |
| Mupirocin | 33 | $287 | $9 |
2016: 17 drugs
| Clobetasol Propionate | 330 | $83,811 | $254 |
| Fluocinonide | 117 | $13,954 | $119 |
| Betamethasone Dipropionate | 57 | $5,590 | $98 |
| Metronidazole | 35 | $5,013 | $143 |
| Econazole Nitrate | 23 | $4,173 | $181 |
| Triamcinolone Acetonide | 250 | $3,889 | $16 |
| Clindamycin Phosphate | 44 | $3,475 | $79 |
| Fluorouracil | 20 | $3,335 | $167 |
| Ketoconazole | 128 | $2,432 | $19 |
| Clotrimazole | 55 | $1,661 | $30 |
| Fluticasone Propionate | 68 | $1,572 | $23 |
| Doxycycline Monohydrate | 51 | $1,341 | $26 |
| Doxycycline Hyclate | 15 | $554 | $37 |
| Mupirocin | 32 | $402 | $13 |
| Hydrocortisone | 53 | $343 | $6 |
| Hydroxyzine | 18 | $163 | $9 |
| Selenium Sulfide | 13 | $153 | $12 |
2015: 13 drugs
| Clobetasol Propionate | 133 | $40,635 | $306 |
| Fluocinonide | 53 | $6,010 | $113 |
| Econazole Nitrate | 22 | $4,720 | $215 |
| Fluorouracil | 18 | $3,393 | $189 |
| Clindamycin Phosphate | 21 | $2,020 | $96 |
| Metronidazole | 12 | $1,719 | $143 |
| Triamcinolone Acetonide | 83 | $1,631 | $20 |
| Ketoconazole | 43 | $1,529 | $36 |
| Betamethasone Dipropionate | 15 | $1,148 | $77 |
| Fluticasone Propionate | 24 | $728 | $30 |
| Hydroxyzine | 24 | $320 | $13 |
| Doxycycline Monohydrate | 18 | $287 | $16 |
| Hydrocortisone | 33 | $227 | $7 |
2014: 6 drugs
| Clobetasol Propionate | 39 | $6,429 | $165 |
| Desonide | 11 | $2,112 | $192 |
| Fluorouracil | 11 | $2,055 | $187 |
| Fluocinonide | 15 | $1,549 | $103 |
| Triamcinolone Acetonide | 28 | $711 | $25 |
| Ketoconazole | 29 | $408 | $14 |
2013: 6 drugs
| Fluocinonide | 25 | $2,074 | $83 |
| Desonide | 17 | $1,607 | $95 |
| Clobetasol Propionate | 24 | $1,562 | $65 |
| Triamcinolone Acetonide | 30 | $598 | $20 |
| Ketoconazole | 20 | $360 | $18 |
| Econazole Nitrate | 12 | $303 | $25 |
Money from drug and device companies
$406 in 2025
| 2025 | 8 | 22 | None | $406 |
| 2024 | 12 | 66 | None | $1,290 |
| 2023 | 9 | 71 | None | $1,182 |
| 2022 | 7 | 36 | None | $624 |
| 2021 | 5 | 7 | None | $154 |
| 2020 | 3 | 18 | None | $167 |
| 2019 | 4 | 14 | None | $192 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Skyrizi | $165 | 9 payments
|
| LEO Pharma | Adbry | $74 | 5 payments
|
| Amgen | Otezla | $66 | 3 payments
|
| Novartis Pharmaceuticals | Cosentyx | $28 | 1 payment
|
| Genzyme | Dupixent | $27 | 1 payment
|
| Botanix SB | Sofdra | $24 | 1 payment
|
See all 22 published payments
| Botanix SB | Meals · 2025-12-17 | Sofdra | $24 |
| LEO Pharma | Meals · 2025-12-15 | Adbry | $14 |
| LEO Pharma | Meals · 2025-12-15 | Adbry | $14 |
| Abbvie | Meals · 2025-12-05 | Skyrizi | $15 |
| LEO Pharma | Meals · 2025-11-19 | Adbry | $14 |
| Abbvie | Meals · 2025-10-20 | Skyrizi | $22 |
| Novartis Pharmaceuticals | Meals · 2025-09-29 | Cosentyx | $28 |
| Abbvie | Meals · 2025-09-23 | Skyrizi | $18 |
| Abbvie | Meals · 2025-09-16 | Skyrizi | $11 |
| LEO Pharma | Meals · 2025-09-05 | Adbry | $17 |
| Abbvie | Meals · 2025-08-28 | Skyrizi | $18 |
| Abbvie | Meals · 2025-06-24 | Skyrizi | $10 |
| LEO Pharma | Meals · 2025-06-20 | Adbry | $15 |
| Abbvie | Meals · 2025-05-23 | Botox | $17 |
| Genzyme | Meals · 2025-04-03 | Dupixent | $27 |
| Abbvie | Meals · 2025-03-27 | Skyrizi | $24 |
| Organon | Meals · 2025-03-07 | Vtama | $6 |
| Amgen | Meals · 2025-03-06 | Otezla | $22 |
| Pfizer | Education · 2025-02-26 | Cibinqo | $15 |
| Amgen | Meals · 2025-01-29 | Otezla | $19 |
| Amgen | Meals · 2025-01-14 | Otezla | $25 |
| Abbvie | Meals · 2025-01-06 | Skyrizi | $30 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,290
| Abbvie | Skyrizi | $457 | 20 payments
|
| LEO Pharma | Adbry | $210 | 19 payments
|
| Amgen | Otezla | $206 | 10 payments
|
| Genzyme | Dupixent | $85 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Cabtreo | $57 | 3 payments
|
| Galderma Laboratories L.P. | Aklief | $54 | 3 payments
|
| Pfizer | Cibinqo | $49 | 2 payments
|
| Dermavant Sciences | Vtama | $43 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $41 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $33 | 1 payment
|
| Arcutis Biotherapeutics | Zoryve | $30 | 1 payment
|
| Organogenesis | Puraply Am | $25 | 1 payment
|
2023: $1,182
| LEO Pharma | Adbry | $412 | 36 payments
|
| AbbVie | Skyrizi | $245 | 14 payments
|
| Janssen Biotech | Tremfya | $186 | 6 payments
|
| Novartis Pharmaceuticals | Cosentyx | $97 | 3 payments
|
| Amgen | Otezla | $65 | 3 payments
|
| Galderma Laboratories L.P. | None | $64 | 3 payments
|
| Ortho Dermatologics a division of Bausch Health US | Arazlo | $43 | 2 payments
|
| Pfizer | Eucrisa | $39 | 2 payments
|
| Biofrontera | Ameluz | $32 | 2 payments
|
2022: $624
| Abbvie | Skyrizi | $325 | 17 payments
|
| LEO Pharma | Adbry | $159 | 13 payments
|
| Novartis Pharmaceuticals | Cosentyx | $50 | 2 payments
|
| Genzyme | Libtayo | $32 | 1 payment
|
| Allergan | Botox | $25 | 1 payment
|
| EPI Health | Cloderm | $20 | 1 payment
|
| Galderma Laboratories L.P. | Twyneo | $14 | 1 payment
|
2021: $154
| Pfizer | Eucrisa | $70 | 2 payments
|
| AbbVie | Humira | $44 | 2 payments
|
| Allergan | Botox | $17 | 1 payment
|
| Janssen Biotech | Remicade | $12 | 1 payment
|
| Sun Pharmaceutical Industries | Absorica Ld | $11 | 1 payment
|
2020: $167
| LEO Pharma | Enstilar | $143 | 16 payments
|
| Sun Pharmaceutical Industries | Absorica Ld | $13 | 1 payment
|
| Galderma Laboratories L.P. | Soolantra | $11 | 1 payment
|
2019: $192
| Janssen Biotech | Tremfya | $129 | 10 payments
|
| Galderma Laboratories L.P. | Epiduo Forte | $31 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Onexton | $21 | 1 payment
|
| Mission Pharmacal | Avar | $11 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1770873804
- Licence
- CA A122412California A122412: Current · expires 2027-11-30
- Trained
- University of Texas Southwestern Medical School at Dallas, 2011
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 3301 C St Ste 1400, Sacramento, CA, 95816
- NPI first listed
- 2011-04-11
- NPI last updated
- 2014-03-17
This is when the NPI record was last certified, not a medical board exam.